- Home
- ISPC vs GLMD Comparison
ISPC vs GLMD Comparison
Compare ISPC & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ISPC | GLMD |
|---|---|---|
| Founded | 2009 | 2000 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8M | 4.2M |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ISPC | GLMD |
|---|---|---|
| Price | $1.67 | $4.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 63.2K | ★ 115.9K |
| Earning Date | 05-18-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,928,998.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.10 | $0.41 |
| 52 Week High | $6.77 | $5.45 |
Technical Indicators
Market Signals| Indicator | ISPC | GLMD |
|---|---|---|
| Relative Strength Index (RSI) | 34.00 | 86.02 |
| Support Level | $0.25 | $0.56 |
| Resistance Level | $2.38 | N/A |
| Average True Range (ATR) | 0.24 | 0.19 |
| MACD | 0.00 | 0.45 |
| Stochastic Oscillator | 10.24 | 75.89 |
Price Performance
Historical ComparisonAbout ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.